Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 8:25 PM ET

Pharmaceuticals

Company Overview of Hi-Tech Pharmacal Co., Inc.

Company Overview

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription, and over-the-counter (OTC) products in the United States. It operates in three segments: Generic Pharmaceuticals, OTC Branded Pharmaceuticals, and Prescription Brands. The company manufactures liquid and semi-solid dosage forms; and produces a range of sterile ophthalmic, otic, and inhalation products. Its generic products include oral solutions and suspensions, topical creams, and ointments, as well as nasal sprays. Hi-Tech Pharmacal Co. also markets OTC branded products, such as Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, Choice DM, and DiabetiSweet ...

369 Bayview Avenue

Amityville, NY 11701

United States

Founded in 1982

447 Employees

Phone:

631-789-8228

Fax:

631-789-8429

Key Executives for Hi-Tech Pharmacal Co., Inc.

Chairman, Chief Executive Officer, President, Secretary and Treasurer
Age: 54
Chief Financial Officer and Vice President of Finance
Age: 46
Vice President of Operations
Age: 51
Chief Executive Officer of ECR Pharmaceuticals and President of ECR Pharmaceuticals
Age: 53
President of Health Care Products Division
Age: 57
Compensation as of Fiscal Year 2014.

Hi-Tech Pharmacal Co., Inc. Key Developments

Hi-Tech Pharmacal Co., Inc.(NasdaqGM:HITK) dropped from Russell 2000 Index

Hi-Tech Pharmacal Co., Inc. will be removed from the Russell 2000 Index.

Hi-Tech Pharmacal Co., Inc.(NasdaqGM:HITK) dropped from Russell 3000 Index

Hi-Tech Pharmacal Co., Inc. will be removed from the Russell 3000 Index.

Hi-Tech Pharmacal Co., Inc.(NasdaqGS:HITK) dropped from S&P 1000 Index

Hi-Tech Pharmacal Co., Inc.(NasdaqGS:HITK) dropped from S&P 1000 Index

Similar Private Companies By Industry

Company Name Region
InCarda Therapeutics, Inc. United States
TREVENTIS Corporation United States
Rivanna Pharmaceuticals Inc. United States
Biosynthema, Inc. United States
Ortho-McNeil Neurologics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 20, 2014
E. Claiborne Robins Company, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Hi-Tech Pharmacal Co., Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.